Table: Pharmarise Holdings - 6-MTH group results

Pharmarise Holdings

25/12/2024 06:00

Dec 25 (Reuters)- 
             Pharmarise Holdings Corp 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended        Year to  
                  Nov 30, 2024        Nov 30, 2023      May 31, 2025  
                     LATEST             YEAR-AGO           LATEST     
                     RESULTS             RESULTS          FORECAST    
  Sales               30.54               26.95             64.73     
                   (+13.3 pct)         (+4.7 pct)        (+18.9 pct)  
  Operating          100 mln             710 mln           350 mln    
                   (-85.8 pct)         (+23.9 pct)       (-61.8 pct)  
  Recurring          29 mln              701 mln           143 mln    
                   (-95.8 pct)         (+23.9 pct)       (-82.8 pct)  
  Net             loss 113 mln           273 mln        loss 214 mln  
                                      (+276.6 pct)                    
  EPS            loss 10.09 yen         28.29 yen      loss 18.98 yen 
  EPS Diluted                           26.99 yen                     
  Ann Div                               20.00 yen         14.00 yen   
  -Q2 div              NIL                 NIL                        
  -Q4 div                               20.00 yen         14.00 yen   
  
  NOTE - Pharmarise Holdings Corp. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T